We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's Why You Should Retain Emerson Stock in Your Portfolio Now
Read MoreHide Full Article
Emerson Electric Co. (EMR - Free Report) is poised to gain from solid momentum in the Intelligent Devices and Software and Control segments. The company’s measures to reward its shareholders are encouraging.
Based in St. Louis, MO, Emerson is a diversified global engineering and technology company. It offers a wide range of products and services to customers in the consumer, commercial and industrial markets. The company boasts a diverse range of brands like Bettis, Crosby, Fisher, Flexim, Micro Motion, Afag, Appleton, ASCO, Greenlee, Klauke, AMS and DeltaV.
EMR currently carries a Zacks Rank #3 (Hold). In the past year, the stock has gained 42.8% compared with the industry’s 28.6% growth.
Image Source: Zacks Investment Research
Let’s discuss the factors that should influence investors to retain this company for the time being.
Business Strength: Emerson has been experiencing healthy demand across most of its end markets. Solid demand in the process and hybrid industries is boosting underlying sales. The company anticipates sales in the process and hybrid industry to grow moderately in fiscal 2025, driven by strength in the energy, LNG and power end markets. Robust demand from sustainability and digital transformation initiatives will also contribute to steady progress.
Also, the company is benefiting from the strong performance of the Intelligent Devices and Software and Control segments. Within the Intelligent Devices segment, it is seeing strength in the Final Control business, driven by solid momentum in the energy and power end markets.
Robust growth in all geographies and strong backlog conversion levels are aiding the Measurement & Analytical business. Within the Software and Control segment, strength in the power, process and hybrid end markets is supporting the Control Systems & Software business. Strength in the aerospace and defense end markets, driven by increasing government spending, is supporting the Test & Measurement business’ growth.
Expansion Efforts: EMR’s expansion initiative is expected to drive growth. In November 2024, it proposed to acquire the remaining shares of AspenTech for $240 per share. This follows Emerson's 55% majority stake in AspenTech, acquired in 2022, and will increase its ownership to 100%, making AspenTech a wholly owned subsidiary.
In the fourth quarter of fiscal 2023, the company completed the acquisitions of Afag and Flexim. The buyout of Afag boosted Emerson’s capabilities in factory automation, helping it expand into lucrative end markets, battery manufacturing, automotive, packaging, medical, life sciences and electronics. The acquisition of Flexim added to its existing flow measurement positions in coriolis, differential pressure, magmeter and vortex flow measurement and expanded its automation portfolio and measurement capabilities.
Rewards to Shareholders: The company’s measures to reward its shareholders through dividend payments are noteworthy. In 2024 (ended September 2024), it paid out dividends of $1.2 billion and repurchased common stocks worth $435 million. In November 2024, the company hiked its dividend by 0.5%. Emerson plans to repurchase shares worth $2 billion and pay out dividends of $1.2 billion in fiscal 2025 (ending September 2025). For fiscal 2025, it expects free cash flow to be in the band of $3.2–$3.3 billion.
Downsides of EMR
Rising Costs: Emerson has been dealing with the adverse impacts of the high cost of sales and operating expenses. Increasing material and freight costs are pushing up the cost of sales, which surged 8.2% in the fourth quarter of fiscal 2024. The impact of these expenditures is evident in the rise of the cost of sales as a percentage of total revenues, which climbed 210 basis points to reach 50.8%. Selling, general and administrative expenses increased 18% to $1.3 billion due to increased acquisition-related and stock compensation expenses.
Forex Woes: The company’s operations are spread across the world, the majority of which are outside the United States. Therefore, it is exposed to global economic and political risks as well as unfavorable movement in foreign currencies.
GHM delivered a trailing four-quarter average earnings surprise of 101.9%. In the past 60 days, the Zacks Consensus Estimate for Graham’s fiscal 2025 earnings has increased 8.4%.
RBC Bearings Incorporated (RBC - Free Report) presently carries a Zacks Rank #2 (Buy). The company delivered a trailing four-quarter average earnings surprise of 2.5%.
In the past 60 days, the consensus estimate for RBC’s fiscal 2025 earnings has increased 2.3%.
Kadant Inc. (KAI - Free Report) presently carries a Zacks Rank of 2. It has a trailing four-quarter average earnings surprise of 17.2%.
The Zacks Consensus Estimate for KAI’s 2024 earnings has increased 1.8% in the past 60 days.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report predicting the 7 stocks that will soar highest in the coming month.
Image: Bigstock
Here's Why You Should Retain Emerson Stock in Your Portfolio Now
Emerson Electric Co. (EMR - Free Report) is poised to gain from solid momentum in the Intelligent Devices and Software and Control segments. The company’s measures to reward its shareholders are encouraging.
Based in St. Louis, MO, Emerson is a diversified global engineering and technology company. It offers a wide range of products and services to customers in the consumer, commercial and industrial markets. The company boasts a diverse range of brands like Bettis, Crosby, Fisher, Flexim, Micro Motion, Afag, Appleton, ASCO, Greenlee, Klauke, AMS and DeltaV.
EMR currently carries a Zacks Rank #3 (Hold). In the past year, the stock has gained 42.8% compared with the industry’s 28.6% growth.
Image Source: Zacks Investment Research
Let’s discuss the factors that should influence investors to retain this company for the time being.
Business Strength: Emerson has been experiencing healthy demand across most of its end markets. Solid demand in the process and hybrid industries is boosting underlying sales. The company anticipates sales in the process and hybrid industry to grow moderately in fiscal 2025, driven by strength in the energy, LNG and power end markets. Robust demand from sustainability and digital transformation initiatives will also contribute to steady progress.
Also, the company is benefiting from the strong performance of the Intelligent Devices and Software and Control segments. Within the Intelligent Devices segment, it is seeing strength in the Final Control business, driven by solid momentum in the energy and power end markets.
Robust growth in all geographies and strong backlog conversion levels are aiding the Measurement & Analytical business. Within the Software and Control segment, strength in the power, process and hybrid end markets is supporting the Control Systems & Software business. Strength in the aerospace and defense end markets, driven by increasing government spending, is supporting the Test & Measurement business’ growth.
Expansion Efforts: EMR’s expansion initiative is expected to drive growth. In November 2024, it proposed to acquire the remaining shares of AspenTech for $240 per share. This follows Emerson's 55% majority stake in AspenTech, acquired in 2022, and will increase its ownership to 100%, making AspenTech a wholly owned subsidiary.
In the fourth quarter of fiscal 2023, the company completed the acquisitions of Afag and Flexim. The buyout of Afag boosted Emerson’s capabilities in factory automation, helping it expand into lucrative end markets, battery manufacturing, automotive, packaging, medical, life sciences and electronics. The acquisition of Flexim added to its existing flow measurement positions in coriolis, differential pressure, magmeter and vortex flow measurement and expanded its automation portfolio and measurement capabilities.
Rewards to Shareholders: The company’s measures to reward its shareholders through dividend payments are noteworthy. In 2024 (ended September 2024), it paid out dividends of $1.2 billion and repurchased common stocks worth $435 million. In November 2024, the company hiked its dividend by 0.5%. Emerson plans to repurchase shares worth $2 billion and pay out dividends of $1.2 billion in fiscal 2025 (ending September 2025). For fiscal 2025, it expects free cash flow to be in the band of $3.2–$3.3 billion.
Downsides of EMR
Rising Costs: Emerson has been dealing with the adverse impacts of the high cost of sales and operating expenses. Increasing material and freight costs are pushing up the cost of sales, which surged 8.2% in the fourth quarter of fiscal 2024. The impact of these expenditures is evident in the rise of the cost of sales as a percentage of total revenues, which climbed 210 basis points to reach 50.8%. Selling, general and administrative expenses increased 18% to $1.3 billion due to increased acquisition-related and stock compensation expenses.
Forex Woes: The company’s operations are spread across the world, the majority of which are outside the United States. Therefore, it is exposed to global economic and political risks as well as unfavorable movement in foreign currencies.
Stocks to Consider
Some better-ranked companies are discussed below.
Graham Corporation (GHM - Free Report) currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
GHM delivered a trailing four-quarter average earnings surprise of 101.9%. In the past 60 days, the Zacks Consensus Estimate for Graham’s fiscal 2025 earnings has increased 8.4%.
RBC Bearings Incorporated (RBC - Free Report) presently carries a Zacks Rank #2 (Buy). The company delivered a trailing four-quarter average earnings surprise of 2.5%.
In the past 60 days, the consensus estimate for RBC’s fiscal 2025 earnings has increased 2.3%.
Kadant Inc. (KAI - Free Report) presently carries a Zacks Rank of 2. It has a trailing four-quarter average earnings surprise of 17.2%.
The Zacks Consensus Estimate for KAI’s 2024 earnings has increased 1.8% in the past 60 days.